Form 4 for MNPR Monopar Therapeutics
Accepted 2026-04-02 15:03:03 ET · period of report 2026-03-31 · accession 0001437749-26-011078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 15:03 | 2026-03-31 | MNPR | Cittadine Andrew | COO | M - OptEx | — | +3,514 | 54.2K | +7% | — |
| D | 2026-04-02 15:03 | 2026-03-31 | MNPR | Cittadine Andrew | COO | F - Tax | $54.79 | -1,571 | 52.7K | -3% | -$86.1K |
| D | 2026-04-02 15:03 | 2026-03-31 | MNPR | Cittadine Andrew | COO | M - OptEx | $0.00 | -3,514 | 44.8K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | M | A | 3,514 | — | 54,240 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Common | Common Stock | 2026-03-31 | F | D | 1,571 | $54.79 | 52,669 | D | — | — | (F2) Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Unit | 2026-03-31 | M | D | 3,514 | $0.00 | 44,753 | D | — · — to — | 3,514 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F3) On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. (F4) On March 4, 2025, the reporting person was granted 40,581 restricted stock units, vesting 6/48ths (5,073 shares) on June 30, 2025, and 3/48ths (2,536 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. (F3) On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. (F4) On March 4, 2025, the reporting person was granted 40,581 restricted stock units, vesting 6/48ths (5,073 shares) on June 30, 2025, and 3/48ths (2,536 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |